Article Details

Kineta to Participate in "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond ...

Retrieved on: 2021-06-07 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Kineta to Participate in "VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond .... View article details on hiswai:

Excerpt

SEATTLE, June 7, 2021 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up